Dayton T. Meyer
Bristol-Myers Squibb (United States) · 18 works · 1,140 citations · h-index 12
Top works
- Corannulene. A convenient new synthesis
- Corannulene. A Three-Step Synthesis 1
- Preparation and Structure−Activity Relationship of Novel P1/P1‘-Substituted Cyclic Urea-Based Human Immunodeficiency Virus Type-1 Protease Inhibitors
- Design, Synthesis, and Structure−Activity Relationships of Macrocyclic Hydroxamic Acids That Inhibit Tumor Necrosis Factor α Release in Vitro and in Vivo
- Design, Synthesis, and Evaluation of Benzothiadiazepine Hydroxamates as Selective Tumor Necrosis Factor-α Converting Enzyme Inhibitors
- Sultam Hydroxamates as Novel Matrix Metalloproteinase Inhibitors
- Macrocyclic Amino Carboxylates as Selective MMP-8 Inhibitors
- Potent carboxylate inhibitors of stromelysin containing P2′ piperazic acids and P1′ biaryl moeities
- Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-α production
- Discovery of Disubstituted Cyclohexanes as a New Class of CC Chemokine Receptor 2 Antagonists
- Potent and selective aggrecanase inhibitors containing cyclic P1 substituents
- ChemInform Abstract: Corannulene. A Three‐Step Synthesis.
- γ-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists
- Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists
- ChemInform Abstract: Potent Carboxylate Inhibitors of Stromelysin Containing P2′ Piperazic Acids and P1′ Biaryl Moieties.
- Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists
- ChemInform Abstract: Preparation and Structure‐Activity Relationship of Novel P1/P1′‐ Substituted Cyclic Urea‐Based Human Immunodeficiency Virus Type‐1 Protease Inhibitors.
- ChemInform Abstract: Thermal Rearrangements of Aromatic Compounds. Part 14. Corannulene: A Convenient New Synthesis.